Actively Recruiting
The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:
Led by University of Roma La Sapienza · Updated on 2026-04-29
150
Participants Needed
1
Research Sites
91 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to assess the effect of a combination of Magnesium, Palmitoylethanolamide, high-molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in women at risk of preterm birth (PTB).
CONDITIONS
Official Title
The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent
- Singleton pregnancy
- Maternal age 63 18 years
- Gestational age between 20+0 and 34+0 weeks at enrollment
- Cervical length between 15 mm and 30 mm measured by transvaginal ultrasound
You will not qualify if you...
- Fetal structural anomalies
- Maternal chronic diseases or pregnancy-related conditions, including diabetes, hypertension, preeclampsia, cardiovascular disease, infections, or autoimmune disorders
- Multiple gestation
- Fetal growth abnormalities (estimated fetal weight <10th or >90th percentile)
- Prelabor rupture of membranes (PROM)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Policlinico Umberto I
Rome, RM, Italy, 00161
Actively Recruiting
Research Team
G
Giuseppe RIZZO, Professor
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here